Vertex (VERX – Research Report) received a Hold rating and price target from Raymond James analyst Alexander Sklar today. The company’s ...

(“Vertex” or the “Company”), a global provider of tax technology solutions, has been named a Leader in three IDC MarketScape reports: IDC MarketScape: Worldwide SaaS and Cloud-Enabled SaaS ...

Vertex remains a trusted partner for organizations worldwide, reinforcing its leadership in an increasingly digitized tax management space. By staying at the forefront of tax technology ...

The first medical treatment to use Crispr gene editing has been on the market for a year. Its complexity means few patients ...

After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes.

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $57.33, along ...

Despite the real problems with the additional indication being sought for suzetrigine, this drop in the stock is still an ...

(“Vertex” or the “Company”), a global provider of tax technology solutions, has been named a Leader in three IDC MarketScape reports: IDC MarketScape: Worldwide SaaS and Cloud-Enabled SaaS ...

Vertex, Inc., a leading provider of tax technology solutions, has been recognized as a Leader in three recent IDC MarketScape reports assessing SaaS and cloud-enabled tax automation software for ...

The VERTEX 80/80v optics design allows PEAK flexibility and PEAK instrument performance at the same time. The unique Bruker Optics DigiTect ™ technology ensures PEAK signal-to-noise ratio ...

The french-fry maker replaced its chief executive and [slashed guidance again]( ...